Economic Value Management (EVM) 2007 results

Similar documents
Economic Value Management (EVM)

CREATING A MAJOR INTERNATIONAL PETCARE BUSINESS. January, 17 th 2001

Building a Global Leader and Creating Value

2017 Disruptive Growth Company Showcase NYC September 27, 2017

Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code Marketing

EUROPEAN COMMISSION EUROSTAT

Veterinary Services Market Global Briefing 2017 Including: Animal Hospitals And Veterinary Clinics And Veterinary Laboratory Testing Services.

ILLUSTRATION GROWTH RATES PENSION FUND RANGE

Veterinary Chemistry Analyzers-Global Market Status and Trend Report

Islay Sustainable Goose Management Strategy. Baseline information summary document

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

Benefit Cost Analysis of AWI s Wild Dog Investment

Regulatory issues. Electricity. Authorisation of amendments to the national electricity code regional pricing of ancillary services

RESPONSIBILITY FOR ANIMAL CONTROL AND POUND FUNDING IN OTTAWA-CARLETON

REGIONAL CONFERENCE ON FACTORING IN AFRICA

CHOICES The magazine of food, farm and resource issues

Omeprazole Capsule TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics

Member Needs Assessment Report to the Members June 2012

2013 AVMA Veterinary Workforce Summit. Workforce Research Plan Details

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011

Veterinary Statutory Bodies: Their roles and importance in the good governance of Veterinary Services

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

EU Programmes for Animal Welfare in the European region

Gemalto N.V. annual information update. for the twelve months up to May 23, 2006

Reflection paper on promotion of pharmacovigilance reporting

Snapshot Current Vet Drugs AMR Initiatives

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION

Questions and Answers on the Community Animal Health Policy

A economic justification for government intervention in the control of wild dogs and primary instrument selection

Earned Value Management Practitioners Symposium

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Using Earned Value in Scientific Research. David Roberts & Sheila Roberts CUPE International.

General Terms and Conditions of the Koninklijke Nederlandse Maatscharmil voor Diergeneeskunde (Royal Netherlands Veterinary Association)

GOVERNED RANGE BALANCED TRACKER LIFESTYLE STRATEGY (DRAWDOWN) FACTSHEET

OIE Standards on Veterinary Legislation: Chapter 3.4 of the OIE Terrestrial Animal Health Code

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK

For personal use only

Animal Shelter Management and Services Agreement

Applicability of Earn Value Management in Sri Lankan Construction Projects

ANIMAL CARE AND USE STANDARD

Policy on Community-based Animal Health Workers

Creating Strategic Capital for EVM. EVA th June 2012 Andrew Hill PROJECT CONTROLS CONSULTING

Draft ESVAC Vision and Strategy

Annual Report Planning 2009

Anatara Investor Presentation

Responsible use of antimicrobials in veterinary practice

New Zealand s Strategy for a more profitable sheep & beef industry. 5 September 2011 P11026

Component Specification NFQ Level 5. Sheep Husbandry 5N Component Details. Sheep Husbandry. Level 5. Credit Value 10

National Action Plan development support tools

OPTERM LEVEL PREMIUM PLANS.

Whistler Animals Galore Annual Report 2015

Strategy 2020 Final Report March 2017

American Protector Plus Underwriting and rates guide

Level 3 Award in Implantation of Identification Microchips in Animals VSMI001 Qualification Handbook

Proceedings of the 11th International Congress of the World Equine Veterinary Association

FORWARD LOOKING STATEMENTS

Overview of the OIE PVS Pathway

international news RECOMMENDATIONS

Habitat For Paws. General Information. Contact Information. At A Glance. Nonprofit. Habitat For Paws Address P.O. Box

Lessons learned from implementing EVM on a large scale IT portfolio at the Department of State

*********************************** Brakke Consulting's Animal Health News & Notes for October 28, 2016 Copyright Brakke Consulting, Inc.

March 18, Richard Avanzino, President Maddie s Fund 2223 Santa Clara Avenue, Suite B Alameda, CA 94501

1/11/2014. Making Your Pet Facility Vision a Reality. A Good Personal Fit. Know Yourself. Susan Briggs

A-FAVP.1 Foundations of Advanced Veterinary Practice

Market Trends influencing the UK egg sector

Epidemiology and Economics of Antibiotic Resistance

OIE AMR Strategy, One Health concept and Tripartite activities

Nestlé PURINA PetCare. BUSINESS REVIEW North America SEPTEMBER Nestlé Purina PetCare

Sweet Pea Kennels New Client Documents. Please to or fax to Name (First and last) Address

Pet Food Sales in Canada

Private Sector Perspectives IFAH (worldwide)

GAO Earned Value Management (EVM) Audit Findings

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

KAZAGRO. National Management Holding. Analytical review of poultry meat market

Case Study: SAP Implementation in Poultry (Hatcheries) Industry

Product Guide Rate Card

Review of Legislation for Veterinary Medicinal Products Version 2

Division of Research University Policy

Annual Report Planning 2010

Veterinary Price Index

Focus group on promotion of PhV for food producing animals MAH view. IFAH-Europe Tony Simon 23rd November 2016

METALLURGICAL COAL FINANCIAL HIGHLIGHTS

Attachment PMN-LL-1. Pro Forma Lead-Lag Summary

Surveillance. Mariano Ramos Chargé de Mission OIE Programmes Department

Case 2:14-cv KJM-KJN Document 2-5 Filed 02/03/14 Page 1 of 6 EXHIBIT E

Missed Appointments We reserve the right to charge a fee for appointments that are made and not attended.

EXCLUSIVE INVESTMENT SUMMARY 1453 DIAMOND HILL ROAD WOONSOCKET, RHODE ISLAND

IRI Pulse Report Pet Care

A pioneer in pet therapeutics: Delivering safe and effective therapeutics that elevate the standard of care in veterinary medicine 1

Factoring Training Workshop

CANADIAN HATCHING EGG PRODUCERS PRESENTATION TO THE SENATE STANDING COMMITTEE ON AGRICULTURE AND FORESTRY

Recognition of Export Controls and Certification Systems for Animals and Animal Products. Guidance for Competent Authorities of Exporting Countries

PROFESSIONAL PRACTICE STANDARD

Multiple District 105 Lioness Clubs. Section 4 Treasurer s Information

Regulatory approaches to ensure the safety of pet food

Your clients need you to help them reach their full dairy potential.

Written Testimony of. Lisa Dolly, Chief Executive Officer, Pershing. on behalf of the. Securities Industry and Financial Markets Association

Welfare on farms: beyond the Five Freedoms. Christopher Wathes

RESPONSIBLE ANTIMICROBIAL USE

Transcription:

Value Management (EVM) 2007 results Analyst and investor conference call Zurich, EVM methodology EVM is Swiss Re s integrated economic measurement and steering framework used for planning, pricing, reserving and managing the business Splits performance of fund raising activities (underwriting) and fund investment activities (asset management) Recognises all profits on new business at inception, changes in estimates as they occur, and excludes future new business Values assets and liilities on a market consistent basis Reflects best estimates Measures performance after capital costs Slide 2 On 31 March 2008 Swiss Re held an EVM teach-in and disclosed EVM figures for 2006 1 1 not reviewed by PwC

EVM 2007 income statement CHF m Profit 2006 2007 New business profit Previous years business profit Total profit after capital costs 3 010 690 3 700 784 909 1 693 Release of capital costs Income before capital costs 3 541 7 241 3 196 4 889 Strong underwriting results were partially offset by investment losses in a deteriorating financial market environment Slide 3 EVM 2007 income statement Business segments CHF m Property & Casualty Life & Health Financial Markets Group items Total 2007 New business profit Previous years business profit 1 768 851 1 247-42 -2 301 70 100 784 909 Total profit after capital costs 2 619 1 205-2 301 170 1 693 Release of capital costs 1 610 1 136 791-341 3 196 Income before capital costs 4 229 2 341-1 510-171 4 889 2006 New business profit Previous years business profit 1 695 137 391 328 995-71 225 3 010 690 Total profit after capital costs 1 832 719 995 154 3 700 Release of capital costs 1 578 1 007 857 99 3 541 Income before capital costs 3 410 1 726 1 852 253 7 241 Slide 4

EVM 2007 key drivers Property & Casualty New business EVM profit on new business up 4%, driven by low natural catastrophe loss levels partially offset by lower volumes in casualty Previous years business Property and Specialty generated an EVM profit of CHF 1 387 million, reflecting improved claims projections across all divisions Casualty generated an EVM loss of CHF -536 million, driven by adverse development in asbestos & environmental and workers compensation business in the US, and large claims by corporate clients Slide 5 EVM 2007 key drivers Life & Health New business Increase of 219%, mainly attributle to large Admin Re transactions (CHF 772 million) and varile annuities Previous years business Traditional Life & Health contributed CHF -19 million, with adverse mortality assumption changes and experience variances on traditional business in North America (CHF -665 million), offset by favourle mortality and morbidity assumption changes and experience variances in Europe (CHF 571 million) and other countries (CHF 75 million) Admin Re contributed CHF -23 million, with favourle morbidity experience that was more than offset by UK reversionary property revaluations and US lapses Slide 6

EVM 2007 key drivers Financial Markets Credit & Rates reported an EVM loss of CHF -1 613 million, mainly attributle to widening credit spreads and the impact of lower riskfree interest rates on a short duration position relative to the benchmark Equities & Alternative Investments reported an EVM profit of CHF 514 million Mark-to-market loss of CHF -1 203 million on two structured credit default swap transactions Slide 7 EVM 2007 investment result 7.9 0.3-8.5-1.2-1.5-0.8-2.3 Mark-tomarket investment return Cost of funds Tax, fx, expenses SCDS mark-tomarket loss EVM income before capital costs Capital costs EVM profit after capital costs Slide 8

EVM 2007 key drivers Group items New business EVM profit on new business is CHF 70 million, reflecting the result of various corporate centre positions and other items excluded from business segment performance measures Previous years business EVM profit on previous years business is CHF 100 million, mainly due to changes in risk capital and pension fund projections, partly offset by tax charges for current and prior years Slide 9 EVM 2006 and 2007 balance sheet 31 Dec 2006 31 Dec 2007 Assets Investments and cash In-force business assets - Property & Casualty -Life& Health -Other Other assets Total assets 222.5 189.2 20.1 167.8 1.3 1.0 412.7 247.4 193.0 18.2 173.3 1.5 0.3 440.7 Liilities In-force business liilities - Property & Casualty -Life& Health -Other Debt Other liilities Total liilities net worth 323.9 81.1 240.4 2.4 24.3 26.3 374.5 38.2 340.9 74.6 263.2 3.1 28.3 33.1 402.3 38.4 Slide 10

EVM 2007 Group economic net worth Overall economic balance sheet Market value assets liilities net worth Group economic net worth (ENW) is the difference between the market value of assets and the economic value of liilities ENW is the EVM estimate of shareholders funds 31.9 38.4 US GAAP shareholders' equity EVM economic net worth Slide 11 Comparison of 2007 US GAAP shareholders equity to ENW by segment Property & Life & Casualty Health Other Total Additional discounting 8.3-3.1 5.2 MtM on assets & debt 2.2 2.2 Reserving basis - GAAP margins -Other 1.6 12.8-0.3-0.9 12.8 0.4 Recognition differences -0.7 0.3 0.4 0.0 Goodwill & other intangibles -6.0-6.0 Additional tax liility -2.4-1.6 0.2-3.8 Other 0.1 0.1 0.1 0.3 Frictional capital costs -0.4-4.2-4.6 Total 6.5 4.0-4.0 6.5 Slide 12

EVM 2007 economic net worth roll forward 50 40 30 20 10 4.9 39.2-1.2-1.0-1.3-2.2 38.4 0 Published ENW 2006 Opening B/S adjustments 2007 Income 2007 Dividend payment Share repurchase and MCS conversions Other incl. FX on ENW ENW 2007 The EVM production process is not subject to the same control environment as annual and quarterly US GAAP reporting EVM 2006 is unaudited, EVM 2007 is subject to a moderate assurance review, in line with the International Standard on Review Engagements 2400 and the Swiss Auditing Standard 910 Slide 13 EVM 2007 required capital by segment EVM capital is the measure of capital that is required to support the business, it takes internal risk, regulatory and rating agency capital requirements into consideration CHF m EVM capital (average) 2007 2006 Property & Casualty 19 165 18 104 Life & Health 11 848 12 183 Financial Markets 3 968 4 381 Group items 210 219 Total 35 191 34 887 P&C increase reflects higher rating agency capital requirements for natural catastrophes L&H decrease reflects reduction of lethal epidemic scenario in the Swiss Re risk model Financial Markets reflects increase in hedging in 2007 Slide 14

EVM 2007 sensitivities Goals and methodology Overall economic balance sheet Market value assets Market value assets Change liilities net worth liilities net worth EVM sensitivities illustrate the impact on actual EVM figures to changes in EVM key parameters. EVM sensitivities are estimated on the following basis: Changes are applied in isolation rather than showing combined effects No management action taken in reaction to changes All sensitivities take into account second order effects (impact on EVM capital and taxes) Slide 15 EVM 2007 sensitivities Group sensitivities Group sensitivities Change in frictional capital costs Increase by 100bps (from 4% to 5%) Equity market shock 10% fall in global equity markets Change in interest rate environment Increase by 100bps Decrease by 100bps Change in 2007 new business profit -0.3 Change in economic net worth as of 31.12.2007-1.3-1.0 0.2-0.8 Slide 16

EVM 2007 sensitivities Life & Health specific (1) Life & Health specific sensitivities Reduce lapse rates by 10% (e.g. from 8% to 7.2%) Mortality and morbidity rates reduced by 5% Mortality Longevity Morbidity Remove all allowance for future mortality improvement Mortality Longevity Change in 2007 new business profit 0.0 0.2-0.2 0.0-0.3 0.9 Change in economic net worth as of 31.12.2007 0.9 3.5-0.3 0.7-5.2 1.1 Slide 17 EVM 2007 sensitivities Life & Health specific (2) Life & Health specific sensitivities Mortality / Longevity trend rates Set future mortality improvement assumption at 1% p.a. (mortality business) Increase future mortality improvement assumption by 100bps p.a. (longevity business) Change in 2007 new business profit 0.2-0.7 Change in economic net worth as of 31.12.2007 3.2-1.0 Slide 18

EVM 2007 sensitivities Property & Casualty Property & Casualty specific sensitivities Change in weighted average term to settlement Increase by 10% Decrease by 10% Projected future claims cost Increase new business claims by 10% (e.g. increase loss ratio from 60% to 66%) Change in 2007 new business profit 0.1-0.1-0.8 Change in economic net worth as of 31.12.2007 0.8-0.8 Slide 19 Corporate calendar & contacts Corporate calendar 05 August 2008 Second Quarter 2008 Results (Conference Call) 08 September 2008 Investors meeting (Monte Carlo) 25 September 2008 Investors day (Zurich) 06 November 2008 Third Quarter 2008 Results (Conference Call) Investor Relations contact Hotline +41 43 285 4444 Slide 20 Susan Holliday +44 20 7933 3890 Andreas Leu +41 43 285 5603 Marc Hermacher +41 43 285 2637 Chris Menth +41 43 285 3878 E-mail Investor_Relations@swissre.com

Cautionary note on non-gaap financial measures This presentation on Value Management ( EVM ) contains non- GAAP financial measures. EVM is not based on US GAAP, which are the principles in accordance with which Swiss Re prepares its financial statements, and should not be viewed as a substitute for US GAAP financial measures. Among other items, the EVM income statement (and its components) should not be viewed as a substitute for the income statement (and its line items) included as part of Swiss Re s US GAAP consolidated financial statements and the economic net worth (ENW) figure should not be viewed as a substitute for shareholders equity as reported in Swiss Re s US GAAP consolidated balance sheet. Nonetheless, Swiss Re believes that EVM provides meaningful measures to evaluate its business. Slide 21 Cautionary note on forward-looking statements Certain statements and illustrations contained herein are forward-looking. These statements and illustrations provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical fact or current fact. Forward-looking statements typically are identified by words or phrases such as anticipate, assume, believe, continue, estimate, expect, foresee, intend, may increase and may fluctuate and similar expressions or by future or conditional verbs such as will, should, would and could. These forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Swiss Re s actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed or implied by such statements. Such factors include, among others: changes in global economic conditions and the risk of a global economic mortality and morbidity experience; downturn; policy renewal and lapse rates; direct and indirect impact of continuing deterioration in the credit markets, and changes in rating agency policies or practices; further adverse rat-ing actions by credit rating agencies in respect of the lowering or loss of one of the financial or claims-paying ratings of one or structured credit products or other credit-related exposures and of monoline more of Swiss Re s subsidiaries; insurance companies; political risks in the countries in which Swiss Re operates or in which it insures the occurrence of other unanticipated market developments or trends; risks; the ility to maintain sufficient liquidity and access to capital markets; extraordinary events affecting Swiss Re s clients and other counterparties, the cyclicality of the reinsurance industry; such as bankruptcies, liquidations and other credit-related events; uncertainties in estimating reserves; risks associated with implementing Swiss Re s business strategies; the effect of market conditions, including the global equity and credit markets, the impact of current, pending and future legislation, regulation and regulatory and the level and volatility of equity prices, interest rates, currency values and and legal actions; other market indices; the impact of significant investments, acquisitions or dispositions, and any changes in Swiss Re s investment results; delays, unexpected costs or other issues experienced in connection with any uncertainties in valuing credit default swaps and other credit-related such transactions, including, in the case of acquisitions, issues arising in instruments; connection with integrating acquired operations; the frequency, severity and development of insured claim events; changing levels of competition; and acts of terrorism and acts of war; operational factors, including the efficacy of risk management and other internal procedures in managing the foregoing risks. These factors are not exhaustive. Swiss Re operates in a continually changing environment and new risks emerge continually. Readers are cautioned not to place undue reliance on forward-looking statements. Swiss Re undertakes no obligation to publicly revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. Slide 22